Romeo Agbayani, MD
Otolaryngology · Greenbrae, CANPI 1205909603
Payments from drug & device makers
Across 146 payments — averaging $100.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intersect ENT, Inc.$12K
- GSK$672
- Stryker$665
- Optinose US, Inc.$226
- Sanofi$185
- Acclarent, Inc$137
- plus $363 from 10 others
What the payments were for
- Speaking & faculty fees$5,25036%
- Travel & lodging$5,16635%
- Food & beverage$4,00527%
- Education$2992%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intersect ENT, Inc. | 33 | $12,473 |
| GSK | 46 | $672 |
| Stryker | 17 | $665 |
| Optinose US, Inc. | 22 | $226 |
| Sanofi | 8 | $185 |
| Acclarent, Inc | 6 | $137 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Aerin Medical Inc. | 2 | $76 |
| Davol Inc. | 1 | $48 |
| Medtronic | 1 | $32 |
| Johnson & Johnson | 1 | $21 |
| Cook Medical LLC | 1 | $19 |
| Hikma Pharmaceuticals USA | 1 | $18 |
| Osteomed LLC | 1 | $18 |
| Itamar Medical Inc | 1 | $17 |
| Novartis | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$14,720 in reported general payments places this provider in the 90th percentile of 1,021 otolaryngology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $82,058 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 46 | $5,187 |
| Ipratropium Bromide | 76 | $3,566 |
| Azelastine Hcl | 15 | $676 |
| Omeprazole | 16 | $372 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 37 | $292 |
| Doxycycline Hyclate | 13 | $191 |
| Prednisone | 24 | $184 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $160 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Greenbrae
- Randall OwRoseville$4.3M
- Amir MoradiVista$2.6M
- Brian WeeksSan Diego$1.6M
- Charles LimbSan Francisco$1.5M
- Andrew BerosSan Diego$688K
- Paul SchalchChula Vista$573K
- Steven DavisTorrance$544K
- Arnaud BewleySacramento$541K
- Keith BlackwellLos Angeles$349K
- Kalpna DurairajSun Valley$348K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.